Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingr'HIV: Immune Response to Shingrix in PLWH > 50 Years
NCT05575830Phase 4Active, not recruiting
- Sponsor
- Alexandra Calmy
- Start
- Dec 2022
- Primary completion
- Apr 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 4 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Alexandra Calmy. Started Dec 2022; status: active, not recruiting.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT05575830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575830.